New device for analyzing lipoproteins in blood to assess cardiovascular risk
Next-Generation Cardiovascular Risk Assessments Via State-Of-The-Art Lipoprotein Characterization
This study is working on a new, easy-to-use device that can quickly and accurately check the levels of important particles in your blood that help show how healthy your heart is, making it simpler and cheaper for you to keep an eye on your heart health.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Electronic Biosciences, INC. NIH-funded |
| Lab location | 1 site (San Diego, United States) |
| Project ID | NIH-11007709 on NIH RePORTER |
What this research studies
This research focuses on developing an innovative analytical device that can accurately measure lipoprotein particles in blood, which are crucial indicators of cardiovascular health. By characterizing the size, concentration, and properties of these lipoproteins, the device aims to provide a more precise assessment of a patient's risk for conditions like atherosclerosis and heart disease. Unlike current tests that are complex and costly, this new technology is designed to be compact, affordable, and suitable for quick, point-of-care testing, making it accessible for regular monitoring. Patients will benefit from a more reliable and efficient way to evaluate their cardiovascular health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for cardiovascular diseases, including those with high cholesterol, diabetes, or a family history of heart conditions.
Not a fit: Patients who are not at risk for cardiovascular diseases or those who do not have any related health concerns may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cardiovascular risk assessments, enabling earlier detection and better management of heart disease.
How similar studies have performed: Other research has shown promise in developing advanced lipoprotein testing methods, indicating that this approach has potential for success.
Where this research is happening
San Diego, United States
- Electronic Biosciences, INC. — San Diego, United States (Active)
Researchers
- Principal investigator: German, Sean — Electronic Biosciences, INC.
- Study coordinator: German, Sean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.